Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
-
Shares outstanding
-
62.7M
-
Number of holders
-
133
-
Total 13F shares, excl. options
-
23.5M
-
Shares change
-
+2.54M
-
Total reported value, excl. options
-
$1.37B
-
Value change
-
+$159M
-
Put/Call ratio
-
1.63
-
Number of buys
-
75
-
Number of sells
-
-61
-
Price
-
$58.30
Significant Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q4 2015
164 filings reported holding SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") as of Q4 2015.
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) has 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.5M shares
of 62.7M outstanding shares and own 37.44% of the company stock.
Largest 10 shareholders include FMR LLC (4.33M shares), VANGUARD GROUP INC (1.33M shares), FRANKLIN RESOURCES INC (1.19M shares), LORD, ABBETT & CO. LLC (1.1M shares), Visium Asset Management, LP (1.08M shares), JPMORGAN CHASE & CO (966K shares), Redmile Group, LLC (958K shares), ALLIANCEBERNSTEIN L.P. (918K shares), EAGLE ASSET MANAGEMENT INC (864K shares), and BB BIOTECH AG (709K shares).
This table shows the top 133 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.